Medical News

RSS

Bacterin International completes $3M private placement of Secured Convertible Promissory Notes

Bacterin International, Inc. (Bacterin), a developer of biological scaffolds for orthopedic indications, today announced the completion of a $3 million private placement of Secured Convertible Promissory Notes led by Middlebury Securities, LLC.

14 Feb 2010

Biden promises to listen to GOP's health care ideas, but some Republicans are not convinced

The health care reform legislation may have been eclipsed recently by the jobs bill and the war in Afghanistan for top billing on the Sunday morning news shows. But Democrats and Republicans still found time to push their positions on health policy Sunday.

14 Feb 2010

Anthem Blue Cross postpones California rate hike

The Los Angeles Times: - "Under pressure from state regulators, Anthem Blue Cross has agreed to postpone its controversial rate increases of up to 39% for individual health insurance policies set for March 1. In an unusual conference call, California Insurance Commissioner Steve Poizner said Anthem executives told him Saturday morning that its March rate hike would not take effect before May 1 for 800,000 individual policyholders in the state" (Lifsher, 2/13).

14 Feb 2010

Today's OpEds: Republicans and Medicare, small business health costs and changes to FEHBP

Republican leaders are now saying they will not participate in the meeting unless the president takes his health reform plan off the table to start over. I understand their concerns with a variety of issues in the current bills, but where you start is not nearly as important as where you finish. After all, fees continue to skyrocket and millions remain uninsured, costing our country in many ways. ... There is no time like the present for Washington to show America that it is interested in governing, not just in campaigning. The cameras will be rolling, and we will be watching (Christine Todd Whitman, 2/12).

14 Feb 2010

Positive interim results from Helix BioPharma's Topical Interferon Alpha-2b Phase II pharmacokinetic study

Helix BioPharma Corp. today announced that the first ten patients that have been enrolled in its Phase II pharmacokinetic study of Topical Interferon Alpha-2b in patients with low-grade cervical lesions have completed the pharmacokinetic primary endpoint analyses with positive findings.

14 Feb 2010

American HomePatient signs eighth forbearance agreement with NexBank, SSB

American HomePatient, Inc., one of the nation’s largest home health care providers, today announced that it has entered into an eighth forbearance agreement with NexBank, SSB, the agent for its senior debt (the “Agent”), and the holders in interest of a majority of the senior debt (the “Forbearance Holders”).

14 Feb 2010

2 Seattle doctors accused of Medicare fraud; CNN offers advice for patients on checking out their doctors

Two Seattle-area doctors are accused of stealing millions from Medicare through fraudulent billing. "In separate grand jury indictments filed in U.S. District Court, federal authorities contend both men followed identical schemes in setting up shell companies designed to defraud the Medicare system."

14 Feb 2010

COBRA extension out of revised Senate jobs bill

"Senate Majority Leader Harry Reid (D-Nev.) is rewriting a jobs bill after Democrats complained of too many concessions to Republicans," The Hill reports. Unlike the bill unveiled hours earlier by Finance Committee Chairman Max Baucus, D-Mont., Reid's measure "does not extend unemployment and COBRA benefits that many in both parties want." Some Democrats are concerned by the change.

14 Feb 2010

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Biologists at UC San Diego have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development.

14 Feb 2010

Diabetic retinopathy: 5.3M U.S adults suffer

Despite major progress in diagnosis and treatment, diabetic retinopathy remains the major cause of blindness in adults under 60 in the U.S., said Thomas C. Lee, director, Retina Institute in The Vision Center at Childrens Hospital Los Angeles, associate professor of clinical ophthalmology at the Keck School of Medicine of the University of Southern California and attending physician at Doheny Eye Institute.

12 Feb 2010

Debiopharm receives AFSSAPS approval of CTA for Debio 0932 inhibitor, triggers milestone payment to Curis

Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis’ and Debiopharm’s August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.

12 Feb 2010

U.S. Court rules in favor of Perrigo over Mucinex patent litigation

Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.

12 Feb 2010

First-quarter fiscal 2010 results announced by Agilent Technologies

Agilent Technologies Inc. today reported revenues of $1.21 billion for the first fiscal quarter ended Jan. 31, 2010, 4 percent above one year ago. First quarter GAAP net income was $79 million, or $0.22 per diluted share. Last year’s first quarter GAAP net income was $64 million, or $0.18 per share.

12 Feb 2010

Critical Conditions wins Mom's Choice Awards for best health/safety book of 2010

Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive by author Martine Ehrenclou, MA, has been awarded its 14th book award by Mom's Choice Awards for best health/safety book of 2010. http://www.momschoiceawards.com/celebrate09.php

12 Feb 2010

Spanish-language media campaign increases number of QuitLine callers

It pays to advertise. It especially pays to advertise in Spanish if you want Spanish speakers to use a telephone helpline to quit smoking.

12 Feb 2010

Euthymics Bioscience signs LOI to acquire DOV Pharmaceutical

Euthymics Bioscience, Inc., a privately held Delaware corporation, today announced that it has signed a non-binding Letter of Intent (LOI) to merge into and acquire DOV Pharmaceutical, Inc. (DOV), a Delaware corporation currently traded on the Pink Sheets, for $2.0 million in cash plus payment of certain of DOV's expenses. DOV believes that the contemplated $2.0 million cash payment to shareholders represents approximately $0.015 per share of DOV common stock. If the transaction is consummated, it is anticipated that DOV will be renamed Euthymics Bioscience, Inc.

12 Feb 2010

Pacific Biomarkers announces second-quarter fiscal 2010 results

Pacific Biomarkers, Inc., a leading provider of specialized biomarker and contract research services, today announced its operating results for the second quarter and first half of FY2010.

12 Feb 2010

U.S. SEC declares Unilife's Form 10 registration statement effective

Unilife Corporation today announced that the US Securities and Exchange Commission (SEC) declared the Company's Form 10 registration statement effective, clearing the path for Unilife Corporation's listing on the NASDAQ.

12 Feb 2010

IntegraMed America prices common stock offering at $7.50 per share

IntegraMed America, Inc. today announced that it has priced a public offering of 2,500,000 shares of its common stock at a price to the public of $7.50 per share, of which 2,000,000 shares are being offered through the underwriters named below and 500,000 shares are being offered directly by IntegraMed to IAT Reinsurance Company Ltd., IntegraMed’s largest stockholder.

12 Feb 2010

BSC extends agreement for MedeAnalytics' Claims Transparency solution

MedeAnalytics, a leading provider of healthcare performance management solutions, announced that Blue Shield of California (BSC) has extended its agreement for MedeAnalytics’ Claims Transparency solution, which powers BSC’s successful Partnership in Operational Excellence and Transparency (POET) program. BSC has partnered with nearly 100 California hospitals to improve claims performance metrics, streamline business processes and accelerate revenue cycles. The POET program has resulted in a significant decrease in the number of claims denials and appeals.

12 Feb 2010

Medical News

Bacterin International completes $3M private placement of Secured Convertible Promissory Notes

Biden promises to listen to GOP's health care ideas, but some Republicans are not convinced

Anthem Blue Cross postpones California rate hike

Today's OpEds: Republicans and Medicare, small business health costs and changes to FEHBP

Positive interim results from Helix BioPharma's Topical Interferon Alpha-2b Phase II pharmacokinetic study

American HomePatient signs eighth forbearance agreement with NexBank, SSB

2 Seattle doctors accused of Medicare fraud; CNN offers advice for patients on checking out their doctors

COBRA extension out of revised Senate jobs bill

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Diabetic retinopathy: 5.3M U.S adults suffer

Debiopharm receives AFSSAPS approval of CTA for Debio 0932 inhibitor, triggers milestone payment to Curis

U.S. Court rules in favor of Perrigo over Mucinex patent litigation

First-quarter fiscal 2010 results announced by Agilent Technologies

Critical Conditions wins Mom's Choice Awards for best health/safety book of 2010

Spanish-language media campaign increases number of QuitLine callers

Euthymics Bioscience signs LOI to acquire DOV Pharmaceutical

Pacific Biomarkers announces second-quarter fiscal 2010 results

U.S. SEC declares Unilife's Form 10 registration statement effective

IntegraMed America prices common stock offering at $7.50 per share

BSC extends agreement for MedeAnalytics' Claims Transparency solution

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News